Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer (Stage III)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04547504
What this trial is testing

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

Who this might be right for
Non-small-cell Lung Cancer
University Hospital, Brest 349
Testing effectiveness (Phase 2)Study completedNCT00698815
What this trial is testing

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7
National Cancer Institute (NCI) 130
Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00431015
What this trial is testing

Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Infinity Pharmaceuticals, Inc. 88
Testing effectiveness (Phase 2)Study completedNCT00278460
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 49
Testing effectiveness (Phase 2)Study completedNCT00117962
What this trial is testing

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 109
Large-scale testing (Phase 3)Looking for participantsNCT07016126
What this trial is testing

D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Guangdong Provincial People's Hospital 70
Large-scale testing (Phase 3)Looking for participantsNCT05800223
What this trial is testing

Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Shanghai Cancer Hospital, China 300
Testing effectiveness (Phase 2)Study completedNCT01266447
What this trial is testing

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+5 more
National Cancer Institute (NCI) 27
Not applicableStudy completedNCT04954885
What this trial is testing

Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity

Who this might be right for
Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8+2 more
Ohio State University Comprehensive Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT03117335
What this trial is testing

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. 560
Testing effectiveness (Phase 2)Active Not RecruitingNCT01770418
What this trial is testing

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
Lung Neoplasms
Proton Collaborative Group 32
Large-scale testing (Phase 3)Study completedNCT03448146
What this trial is testing

A Trial of PTS Via Intratumoral Injection in Patients With Central Air Way NSCLC Severe Obstruction

Who this might be right for
Nsclc
PTS International Inc. 90
Early research (Phase 1)UnknownNCT04193098
What this trial is testing

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

Who this might be right for
Non-small Cell Lung CancerSecond-line Treatment
Tianjin Medical University Cancer Institute and Hospital 10
Not applicableLooking for participantsNCT07164885
What this trial is testing

RAPART in Locally Advanced Non-small Cell Lung Cancer Patients

Who this might be right for
Locally Advanced Non-small Cell Lung Cancer
Capital Medical University 911
Large-scale testing (Phase 3)Study completedNCT00049998
What this trial is testing

Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
GlaxoSmithKline 760
Testing effectiveness (Phase 2)UnknownNCT00021008
What this trial is testing

ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00002519
What this trial is testing

Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 6
Large-scale testing (Phase 3)Ended earlyNCT00050336
What this trial is testing

Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)

Who this might be right for
Carcinoma, Non-small-cell LungMetastases, Neoplasm
Merck Sharp & Dohme LLC 702
Early research (Phase 1)Study completedNCT01131234
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more
National Cancer Institute (NCI) 20
Next Page